TickerGuard
Buy Day today: Neutral (45) Mixed market breadth · no major macro event
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.355$ -1.4% vs. previous close Closing price · As of: Nov 17, 2026

Statements

Balance Sheet

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 148 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VXRT
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
92 89 114 167 166 159 164 209 186 180 165 148
46 44 72 66 68 63 70 117 136 132 117 96
35 27 43 22 25 29 20 17 54 51 51 35
40 37 63 59 52 42 26 29 64 61 64 66
3.0 2.3 4.8 3.7 12 16 41 86 51 58 47 31
0.0 0.0 – -4.1 – – – – – – – –
4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
4.3 4.1 3.9 3.7 3.6 3.4 3.2 3.0 2.8 2.6 2.5 2.3
34 33 34 98 107 113 131 182 98 86 83 82
14 14 16 80 91 99 118 169 87 77 73 74
6.5 5.2 5.6 5.6 7.1 3.3 3.5 3.8 3.0 2.5 2.5 5.3
1.6 4.0 3.6 2.5 7.0 17 11 53 21 24 17 30
58 56 80 68 59 46 33 27 88 94 82 66
-410 -434 -450 -465 -477 -492 -507 -515 -460 -455 -469 -486
177 177 177 177 228 228 228 229 230 242 242 243

Data as of: November 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?